Hepatopulmonary syndrome after living donor liver transplantation and deceased donor liver transplantation: a single-center experience. 2004

Elizabeth J Carey, and David D Douglas, and Vijayan Balan, and Hugo E Vargas, and Thomas J Byrne, and Adyr A Moss, and David C Mulligan
Division of Transplantation Medicine, Mayo Clinic, Scottsdale, Arizona, USA.

Hepatopulmonary syndrome (HPS) is a progressive, debilitating complication of end-stage liver disease. In contrast to the well-established reversal of HPS after deceased donor liver transplantation (DDLT), little has been written about the natural course of HPS after the newer procedure of living donor liver transplantation (LDLT). We describe HPS in a small series of 4 liver transplant recipients (2 DDLT; 2 LDLT) at a single center. Before transplantation, these 4 patients had a mean shunt fraction of 23.6 +/- 14.3% and a mean PaO2 of 58.5 +/- 11.3 mm Hg. All 4 patients used supplemental oxygen before transplantation. Sixteen weeks after transplantation, all 4 patients had normalized or improved shunt fraction and PaO2. These patients regained normal pulmonary function within a few months, despite the period of hepatic regeneration after LDLT. In conclusion, both DDLT and LDLT are associated with rapid and dramatic reversal of HPS.

UI MeSH Term Description Entries
D008115 Liver Regeneration Repair or renewal of hepatic tissue. Liver Regenerations,Regeneration, Liver,Regenerations, Liver
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D016031 Liver Transplantation The transference of a part of or an entire liver from one human or animal to another. Grafting, Liver,Hepatic Transplantation,Liver Transplant,Transplantation, Hepatic,Transplantation, Liver,Hepatic Transplantations,Liver Grafting,Liver Transplantations,Liver Transplants,Transplant, Liver
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D019520 Living Donors Non-cadaveric providers of organs for transplant to related or non-related recipients. Donors, Living,Donor, Living,Living Donor
D020065 Hepatopulmonary Syndrome A syndrome characterized by the clinical triad of advanced chronic liver disease, pulmonary vascular dilatations, and reduced arterial oxygenation (HYPOXEMIA) in the absence of intrinsic cardiopulmonary disease. This syndrome is common in the patients with LIVER CIRRHOSIS or portal hypertension (HYPERTENSION, PORTAL). Hepato-Pulmonary Syndrome,Hepato Pulmonary Syndrome,Hepato-Pulmonary Syndromes,Hepatopulmonary Syndromes,Syndrome, Hepato-Pulmonary,Syndrome, Hepatopulmonary,Syndromes, Hepato-Pulmonary,Syndromes, Hepatopulmonary

Related Publications

Elizabeth J Carey, and David D Douglas, and Vijayan Balan, and Hugo E Vargas, and Thomas J Byrne, and Adyr A Moss, and David C Mulligan
April 2010, Transplantation proceedings,
Elizabeth J Carey, and David D Douglas, and Vijayan Balan, and Hugo E Vargas, and Thomas J Byrne, and Adyr A Moss, and David C Mulligan
January 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
Elizabeth J Carey, and David D Douglas, and Vijayan Balan, and Hugo E Vargas, and Thomas J Byrne, and Adyr A Moss, and David C Mulligan
January 2009, Annals of hepatology,
Elizabeth J Carey, and David D Douglas, and Vijayan Balan, and Hugo E Vargas, and Thomas J Byrne, and Adyr A Moss, and David C Mulligan
September 2011, Journal of clinical and experimental hepatology,
Elizabeth J Carey, and David D Douglas, and Vijayan Balan, and Hugo E Vargas, and Thomas J Byrne, and Adyr A Moss, and David C Mulligan
June 2020, Journal of clinical laboratory analysis,
Elizabeth J Carey, and David D Douglas, and Vijayan Balan, and Hugo E Vargas, and Thomas J Byrne, and Adyr A Moss, and David C Mulligan
July 2011, Indian journal of nephrology,
Elizabeth J Carey, and David D Douglas, and Vijayan Balan, and Hugo E Vargas, and Thomas J Byrne, and Adyr A Moss, and David C Mulligan
January 2021, Indian journal of nephrology,
Elizabeth J Carey, and David D Douglas, and Vijayan Balan, and Hugo E Vargas, and Thomas J Byrne, and Adyr A Moss, and David C Mulligan
January 2017, Indian journal of nephrology,
Elizabeth J Carey, and David D Douglas, and Vijayan Balan, and Hugo E Vargas, and Thomas J Byrne, and Adyr A Moss, and David C Mulligan
May 2006, Transplantation proceedings,
Elizabeth J Carey, and David D Douglas, and Vijayan Balan, and Hugo E Vargas, and Thomas J Byrne, and Adyr A Moss, and David C Mulligan
April 2010, Transplantation proceedings,
Copied contents to your clipboard!